These results again indicated that (a) the activity of -1797 p27 recapitulated the differential breast cancer preventive efficacy of genistein and genistin and that (b) the estrogen receptor (ER) was not involved in the activation of -1797 p27. The gene discussed is CDKN1B; the disease is breast carcinoma.